CARLSON CAPITAL L P - APTOSE BIOSCIENCES INC ownership

APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 53 filers reported holding APTOSE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CARLSON CAPITAL L P ownership history of APTOSE BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$1,056,000
-7.1%
1,650,000
-15.8%
0.10%
+13.8%
Q4 2022$1,136,800
-4.9%
1,960,000
-2.5%
0.09%
-3.3%
Q3 2022$1,196,000
-15.5%
2,010,000
+5.4%
0.09%
-7.2%
Q2 2022$1,416,000
-33.5%
1,907,500
+21.9%
0.10%
-33.6%
Q1 2022$2,128,000
+12.6%
1,564,700
+11.8%
0.15%
+33.9%
Q4 2021$1,890,000
+20.4%
1,400,000
+94.3%
0.11%
+31.3%
Q3 2021$1,570,000
-7.3%
720,408
+41.3%
0.08%
+1.2%
Q2 2021$1,693,000
-29.2%
510,000
+27.5%
0.08%
-7.9%
Q1 2021$2,390,000
+118.3%
400,000
+60.0%
0.09%
+128.2%
Q4 2020$1,095,000250,0000.04%
Other shareholders
APTOSE BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Corriente Advisors, LLC 2,900,000$12,702,0003.02%
P.A.W. CAPITAL CORP 750,000$3,285,0002.90%
Prosight Management, LP 824,795$3,613,0001.67%
Voss Capital, LLC 715,000$3,132,0001.58%
DRW Securities, LLC 7,976,176$34,936,0001.23%
Ally Bridge Group (NY) LLC 1,409,150$6,172,0001.06%
Nantahala Capital Management 7,272,673$31,854,0000.99%
SANDERS MORRIS HARRIS LLC 925,153$4,231,0000.96%
PRECEPT MANAGEMENT LLC 440,696$1,930,0000.78%
Endurant Capital Management LP 477,895$2,093,0000.76%
View complete list of APTOSE BIOSCIENCES INC shareholders